Author/Creator: Kremers, W. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Kremers, W.

1. A phase III randomized controlled study on the efficacy and improved bowel function of prolonged‐release (PR) oxycodone‐naloxone (up to 160/80 mg daily) vs oxycodone PR. (22nd June 2017)

Authors:: Dupoiron, D.; Stachowiak, A.; Loewenstein, O.; Ellery, A.; Kremers, W.; Bosse, B.; Hopp, M.
Journal:: European journal of pain
Issue:: Volume 21:Number 9(2017)
Page Start:: 1528
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Acute Pancreas Allograft Rejection Is Associated With Increased Risk of Graft Failure in Pancreas Transplantation. Issue 4 (22nd February 2013)

Authors:: Dong, M.; Parsaik, A. K.; Kremers, W.; Sun, A.; Dean, P.; Prieto, M.; Cosio, F. G.; Gandhi, M. J.; Zhang, L.; Smyrk, T. C.; Stegall, M. D.; Kudva, Y. C.
Journal:: American journal of transplantation
Issue:: Volume 13:Issue 4(2013:Apr.)
Page Start:: 1019
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Acute Pancreas Allograft Rejection Is Associated With Increased Risk of Graft Failure in Pancreas Transplantation. Issue 4 (22nd February 2013)

Authors:: Dong, M.; Parsaik, A. K.; Kremers, W.; Sun, A.; Dean, P.; Prieto, M.; Cosio, F. G.; Gandhi, M. J.; Zhang, L.; Smyrk, T. C.; Stegall, M. D.; Kudva, Y. C.
Journal:: American journal of transplantation
Issue:: Volume 13:Issue 4(2013:Apr.)
Page Start:: 1019
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Cytomegalovirus disease is associated with higher all‐cause mortality after lung transplantation despite extended antiviral prophylaxis. Issue 3 (1st March 2016)

Authors:: Beam, E.; Lesnick, T.; Kremers, W.; Kennedy, C.C.; Razonable, R.R.
Journal:: Clinical transplantation
Issue:: Volume 30:Issue 3(2016)
Page Start:: 270
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Long‐term efficacy and safety of oxycodone‐naloxone prolonged‐release formulation (up to 180/90 mg daily) – results of the open‐label extension phase of a phase III multicenter, multiple‐dose, randomized, controlled study. (4th May 2017)

Authors:: Dupoiron, D.; Stachowiak, A.; Loewenstein, O.; Ellery, A.; Kremers, W.; Bosse, B.; Hopp, M.
Journal:: European journal of pain
Issue:: Volume 21:Number 9(2017)
Page Start:: 1485
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗